Novartis Investigative Site

Essen, Nordrhine Westphalia 45136

0 studies enrolling now · 2 studies all time

What they study most

Diabetic Nephropathy, Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Studies at this site

• Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) — Stopped early
• Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy — Completed